Cargando…
Quantitative analysis of tumor shrinkage due to chemotherapy and its implication for radiation treatment planning in limited-stage small-cell lung cancer
BACKGROUND: The optimal timing of chemoradiotherapy in limited-stage small-cell lung cancer (LS-SCLC) hasn’t been established, although evidence from studies supported that patients can benefit from early radiation therapy. The purpose of this study was to quantify tumor shrinkage in response to ind...
Autores principales: | Xia, Bing, Wang, Jia-Zhou, Liu, Qi, Cheng, Jing-Yi, Zhu, Zheng-Fei, Fu, Xiao-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851276/ https://www.ncbi.nlm.nih.gov/pubmed/24040865 http://dx.doi.org/10.1186/1748-717X-8-216 |
Ejemplares similares
-
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
por: Xia, Bing, et al.
Publicado: (2011) -
Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017) -
On Reverse Shrinkage Effects and Shrinkage Overshoot
por: Jordan, Pascal
Publicado: (2022) -
One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022) -
Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy
por: Doshita, Kosei, et al.
Publicado: (2022)